Combined team brings together 200+ experts driving expansion of comprehensive, integrated marketing, and communications solutions for leading pharma, biotech, and life sciences organizations at every stage and size
Deerfield Group, an integrated marketing and communications partner for leading healthcare and life sciences companies, announced the acquisition of Triple Threat Communications (TTC), an award-winning New Jersey-based healthcare strategic marketing agency. The acquisition augments Deerfield’s existing marketing, communications, media, and data analytics capabilities with greater depth in strategy, creative, digital, and medical communications. Tim Frank, TTC Owner and Managing Partner, will join Deerfield’s Executive Leadership team and continue to lead client business across the agency.
Health Technology Insights: Johnson & Johnson Seeks EMA Approval to Extend AKEEGA Use for Prostate Cancer
“As the healthcare landscape grows more complex, our clients are looking for partners who bring both depth and agility—seasoned expertise paired with smart, scalable solutions,” said Frank Burrell, CEO of Deerfield. “The addition of TTC to Deerfield Group represents a significant step forward in our growth journey. With their strong track record of strategy, creative, and digital pharmaceutical marketing, we’re not only deepening our core capabilities but also expanding into new categories and forging relationships with a range of new clients in the U.S. and globally. It’s a powerful next step in our continued evolution as the go-to partner for healthcare companies at every stage of their marketing and communications journey.”
Established in 2005, TTC is known for its award-winning client service, creative, editorial, and production services, supporting a portfolio of mid-size and large pharmaceutical companies in the U.S. and globally. The team’s experienced experts and distinct-yet-complementary expertise further elevates Deerfield’s position as a trusted agency partner and is expected to support future growth and business development opportunities.
Health Technology Insights: ACA Pharma Secures Fast-track Approval For Eagle Pharmaceuticals’ Ryanodex In Macau
“Deerfield is the ideal partner for TTC—an organization with an aligned culture that prioritizes client impact, trusted partnership, and brands above all else,” said Tim Frank of TTC. “Our team has always been driven by a clear purpose to deliver exceptional service and deep expertise to every client we serve through a nimble and uncomplicated agency model. By joining forces with a like-minded agency that shares our values and commitment to a client-first approach, we are expanding our ability to solve complex healthcare challenges with even greater scale and integration. As TTC marks its 20th anniversary, this is the next evolution in the growth and expansion of the agency and the impact we can deliver for clients.”
The TTC acquisition is the latest strategic investment by Deerfield, including the successful integrations of Verge Scientific Communications and Embedded in 2022 and 2024, respectively. These additions have propelled Deerfield to deliver integrated marketing and communications services and counsel to a growing portfolio of clients from early-stage biotech to commercialized pharmaceutical companies. Deerfield was recently ranked 38th in MM&M’s Agency 100 rankings, with 31 percent growth in 2024.
Health Technology Insights: Rhode Island Creates Rare Disease Advisory Council
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source : PR Newswire
